Stratos Wealth Partners LTD. Has $7.74 Million Stock Holdings in Zoetis Inc. $ZTS

Stratos Wealth Partners LTD. decreased its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 10.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 61,507 shares of the company’s stock after selling 7,311 shares during the period. Stratos Wealth Partners LTD.’s holdings in Zoetis were worth $7,739,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in ZTS. Vanguard Group Inc. increased its holdings in Zoetis by 1.0% in the third quarter. Vanguard Group Inc. now owns 42,306,764 shares of the company’s stock worth $6,190,326,000 after purchasing an additional 419,777 shares in the last quarter. Nordea Investment Management AB boosted its holdings in shares of Zoetis by 79.2% during the 4th quarter. Nordea Investment Management AB now owns 4,932,787 shares of the company’s stock worth $622,222,000 after buying an additional 2,179,578 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in shares of Zoetis by 14.6% during the 3rd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,312,779 shares of the company’s stock worth $631,046,000 after buying an additional 550,859 shares during the period. Alliancebernstein L.P. increased its stake in shares of Zoetis by 13.3% in the 3rd quarter. Alliancebernstein L.P. now owns 4,241,357 shares of the company’s stock valued at $620,595,000 after acquiring an additional 496,320 shares in the last quarter. Finally, Fundsmith LLP increased its stake in shares of Zoetis by 25.3% in the 3rd quarter. Fundsmith LLP now owns 3,615,131 shares of the company’s stock valued at $528,966,000 after acquiring an additional 730,300 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on ZTS shares. Weiss Ratings lowered shares of Zoetis from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, March 27th. UBS Group set a $136.00 price target on shares of Zoetis in a research note on Thursday, January 29th. William Blair reiterated an “outperform” rating on shares of Zoetis in a report on Monday, March 2nd. Bank of America increased their price objective on shares of Zoetis from $135.00 to $140.00 and gave the stock a “neutral” rating in a research report on Friday, February 13th. Finally, HSBC set a $140.00 target price on Zoetis in a research note on Wednesday, December 10th. Six equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $152.91.

Zoetis Stock Performance

NYSE ZTS opened at $117.83 on Friday. The company has a fifty day simple moving average of $122.71 and a 200 day simple moving average of $128.09. Zoetis Inc. has a 12-month low of $113.29 and a 12-month high of $172.23. The company has a current ratio of 3.03, a quick ratio of 1.94 and a debt-to-equity ratio of 2.71. The company has a market cap of $49.74 billion, a P/E ratio of 19.57, a PEG ratio of 1.80 and a beta of 0.98.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Thursday, February 12th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.08. Zoetis had a net margin of 28.24% and a return on equity of 62.02%. The business had revenue of $2.39 billion during the quarter, compared to analyst estimates of $2.36 billion. During the same quarter in the previous year, the business posted $1.40 EPS. Zoetis’s quarterly revenue was up 3.0% on a year-over-year basis. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Sell-side analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be given a dividend of $0.53 per share. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 annualized dividend and a dividend yield of 1.8%. Zoetis’s payout ratio is presently 35.22%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.